AAAAAA

   
Results: 1-13 |
Results: 13
PROFOUND THROMBOCYTOPENIA IN PREVIOUSLY TREATED PATIENTS WITH RECURRENT OVARIAN-CARCINOMA RECEIVING TOPOTECAN
Authors: CASS I KUO DY FIELDS AL RUNOWICZ CD GOLDBERG GL
Citation: I. Cass et al., PROFOUND THROMBOCYTOPENIA IN PREVIOUSLY TREATED PATIENTS WITH RECURRENT OVARIAN-CARCINOMA RECEIVING TOPOTECAN, Gynecologic oncology, 69(2), 1998, pp. 175-176
INDUCTION OF TRANSFORMING-GROWTH-FACTOR BETA-1 IN CERVICAL INTRAEPITHELIAL NEOPLASIA IN-VIVO AFTER TREATMENT WITH BETA-CAROTENE
Authors: COMERCI JT RUNOWICZ CD FIELDS AL ROMNEY SL PALAN PR KADISH AS GOLDBERG GL
Citation: Jt. Comerci et al., INDUCTION OF TRANSFORMING-GROWTH-FACTOR BETA-1 IN CERVICAL INTRAEPITHELIAL NEOPLASIA IN-VIVO AFTER TREATMENT WITH BETA-CAROTENE, Clinical cancer research, 3(2), 1997, pp. 157-160
EXPRESSION OF RETINOIC ACID RECEPTOR-BETA-2 MESSENGER-RNA IN NORMAL CERVICAL EPITHELIUM AND CERVICAL SQUAMOUS-CELL CARCINOMA
Authors: COMERCI JT HALLAM S GOLDBERG GL RUNOWICZ CD FIELDS AL WADLER S GALLAGHER RE
Citation: Jt. Comerci et al., EXPRESSION OF RETINOIC ACID RECEPTOR-BETA-2 MESSENGER-RNA IN NORMAL CERVICAL EPITHELIUM AND CERVICAL SQUAMOUS-CELL CARCINOMA, International journal of oncology, 11(5), 1997, pp. 983-988
ENDOMETRIOID ADENOCARCINOMA OF THE OVARY AND LONG-TERM TAMOXIFEN THERAPY - A COINCIDENCE OR A CAUSE FOR CONCERN
Authors: KUO DYS JONES J FIELDS AL RUNOWICZ CD GOLDBERG GL
Citation: Dys. Kuo et al., ENDOMETRIOID ADENOCARCINOMA OF THE OVARY AND LONG-TERM TAMOXIFEN THERAPY - A COINCIDENCE OR A CAUSE FOR CONCERN, European journal of gynaecological oncology, 18(6), 1997, pp. 457-460
PELVIC EXENTERATION FOR CERVIX CANCER - WOULD ADDITIONAL INTRAOPERATIVE INTERSTITIAL BRACHYTHERAPY IMPROVE SURVIVAL
Authors: BEITLER JJ ANDERSON PS WADLER S RUNOWICZ CD HAYES MK FIELDS AL SOOD B GOLDBERG GL
Citation: Jj. Beitler et al., PELVIC EXENTERATION FOR CERVIX CANCER - WOULD ADDITIONAL INTRAOPERATIVE INTERSTITIAL BRACHYTHERAPY IMPROVE SURVIVAL, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 143-148
CONTINUOUS LOW-DOSE COMBINED HORMONE REPLACEMENT THERAPY AND THE RISKOF ENDOMETRIAL CANCER
Authors: COMERCI JT FIELDS AL RUNOWICZ CD GOLDBERG GL
Citation: Jt. Comerci et al., CONTINUOUS LOW-DOSE COMBINED HORMONE REPLACEMENT THERAPY AND THE RISKOF ENDOMETRIAL CANCER, Gynecologic oncology, 64(3), 1997, pp. 425-430
ANALYSIS OF MDR1 EXPRESSION IN NORMAL AND MALIGNANT ENDOMETRIUM BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND IMMUNOHISTOCHEMISTRY
Authors: KUO DYS MALLICK S SHEN HJ DEVICTORIA C JONES J FIELDS AL GOLDBERG GL RUNOWICZ CD HORWITZ SB
Citation: Dys. Kuo et al., ANALYSIS OF MDR1 EXPRESSION IN NORMAL AND MALIGNANT ENDOMETRIUM BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND IMMUNOHISTOCHEMISTRY, Clinical cancer research, 2(12), 1996, pp. 1981-1992
MATURE RESULTS OF A PHASE-II TRIAL OF CONCOMITANT CISPLATIN PELVIC RADIOTHERAPY FOR LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX/
Authors: FIELDS AL ANDERSON PS GOLDBERG GL WADLER S BEITLER J SOOD B RUNOWICZ CD
Citation: Al. Fields et al., MATURE RESULTS OF A PHASE-II TRIAL OF CONCOMITANT CISPLATIN PELVIC RADIOTHERAPY FOR LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX/, Gynecologic oncology, 61(3), 1996, pp. 416-422
THE GENETICS OF OVARIAN-CANCER - AN ASSESSMENT OF CURRENT SCREENING PROTOCOLS AND RECOMMENDATIONS FOR COUNSELING FAMILIES AT RISK
Authors: BOMBARD AT FIELDS AL AUFOX S BENYISHAY M
Citation: At. Bombard et al., THE GENETICS OF OVARIAN-CANCER - AN ASSESSMENT OF CURRENT SCREENING PROTOCOLS AND RECOMMENDATIONS FOR COUNSELING FAMILIES AT RISK, Clinical obstetrics and gynecology, 39(4), 1996, pp. 860-872
ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN CERVICAL NEOPLASIA AS AN EARLY BIOMARKER IN CARCINOGENESIS OF THE UTERINE CERVIX
Authors: COMERCI JT RUNOWICZ CD FLANDERS KC DEVICTORIA C FIELDS AL KADISH AS GOLDBERG GL
Citation: Jt. Comerci et al., ALTERED EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN CERVICAL NEOPLASIA AS AN EARLY BIOMARKER IN CARCINOGENESIS OF THE UTERINE CERVIX, Cancer, 77(6), 1996, pp. 1107-1114
PROMISING NEW THERAPIES IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
Authors: RUNOWICZ CD FIELDS AL GOLDBERG GL
Citation: Cd. Runowicz et al., PROMISING NEW THERAPIES IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, Cancer, 76(10), 1995, pp. 2028-2033
PROMISING NEW THERAPIES IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
Authors: RUNOWICZ CD FIELDS AL GOLDBERG GL
Citation: Cd. Runowicz et al., PROMISING NEW THERAPIES IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, Cancer, 75(10), 1995, pp. 2638-2639
LONG-TERM FOLLOW-UP OF STAGE-I CERVICAL ADENOCARCINOMA TREATED BY RADICAL SURGERY
Authors: MCLELLAN R DILLON MB WOODRUFF JD HEATLEY GJ FIELDS AL ROSENSHEIN NB
Citation: R. Mclellan et al., LONG-TERM FOLLOW-UP OF STAGE-I CERVICAL ADENOCARCINOMA TREATED BY RADICAL SURGERY, Gynecologic oncology, 52(2), 1994, pp. 253-259
Risultati: 1-13 |